Theoretical and Natural Science
- The Open Access Proceedings Series for Conferences
Theoretical and Natural Science
Vol. 22, 20 December 2023
Open
Access | Article
Bacteria in the cancer therapy
* Author to whom correspondence should be addressed.
Abstract
Human has been fighting with cancer for 130 years since the first tumor radical surgery in 1884. During this 130 years of cancer treatment history, there has developed mainly 4 types of treatment, chemotherapy, radiotherapy, surgery and immunotherapy. .However all of these treatment have their own side-effect, including the harm to normal cells, high cost, long developing time. And traditional cancer treatment are often failed to eliminate all the tumor tissue so few patients can be cure completely. Developing an effective cancer treatment is still a challenge. Luckily, a special approach is developing rapidly which is called bacteriotherapy. It can be combined with traditional treatment like chemotherapy and immunotherapy, use bacteria as a vector to deliver the drug or tumor suppressing gene to the tumor. In this way, the effect of harming normal cells can be reduce and the accuracy of attacking tumor can be improved. There are also tumor-specific bacteria found living in tumor which can be effective in cancer treatment. How to use bacteria well in cancer treatment is remain a challenge. This article reviewed the advantages of using bacteria for cancer treatment and the mechanism of bacteria in cancer treatment, giving example of the use of intestinal bacteria, involving the challenge and future of bacteriotherapy.
Keywords
bacteriotherapy, intestine bacteria, genetic modification, target, tumor microenvironment
References
1. Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Piñeros M, Znaor A, Bray F. Cancer statistics for the year 2020: An overview. Int J Cancer. 2021 Apr 5.
2. Bushyhead D, Quigley EM. Small Intestinal Bacterial Overgrowth. Gastroenterol Clin North Am. 2021 Jun;50(2):463-474.
3. Galeano Niño JL, Wu H, LaCourse KD, Kempchinsky AG, Baryiames A, Barber B, Futran N, Houlton J, Sather C, Sicinska E, Taylor A, Minot SS, Johnston CD, Bullman S. Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer. Nature. 2022 Nov;611(7937):810-817.
4. Choe A, Mutsaers A, Rodrigues G, Chin J, Leung S, Winquist E. Spontaneous Remission of Metastatic Castration-Resistant Prostate Cancer: Coley's Toxin Revisited? Cureus. 2022 Dec 14;14(12):e32505.
5. Dobosz P, Dzieciątkowski T. The Intriguing History of Cancer Immunotherapy. Front Immunol. 2019 Dec 17;10:2965.
6. Cheng L, Qi C, Yang H, Lu M, Cai Y, Fu T, Ren J, Jin Q, Zhang X. gutMGene: a comprehensive database for target genes of gut microbes and microbial metabolites. Nucleic Acids Res. 2022 Jan 7;50(D1):D795-D800.
7. CN109593693B A strain of Escherichia coli Nissle 1917 targeting tumor engineering bacteria and its construction method and application.
8. Lee J, Kim S, Kang CH. Immunostimulatory Activity of Lactic Acid Bacteria Cell-Free Supernatants through the Activation of NF-κB and MAPK Signaling Pathways in RAW 264.7 Cells. Microorganisms. 2022 Nov 13;10(11):2247.
9. Patyar S, Joshi R, Byrav DS, Prakash A, Medhi B, Das BK. Bacteria in cancer therapy: a novel experimental strategy. J Biomed Sci. 2010 Mar 23;17(1):21.
10. Divyashree M, Prakash SK, Aditya V, Aljabali AA, Alzahrani KJ, Azevedo V, Góes-Neto A, Tambuwala MM, Barh D. Bugs as drugs: neglected but a promising future therapeutic strategy in cancer. Future Oncol. 2022 Apr;18(13):1609-1626.
11. Kalia VC, Patel SKS, Cho BK, Wood TK, Lee JK. Emerging applications of bacteria as antitumor agents. Semin Cancer Biol. 2022 Nov;86(Pt 2):1014-1025.
12. Kohli K, Pillarisetty VG, Kim TS. Key chemokines direct migration of immune cells in solid tumors. Cancer Gene Ther. 2022 Jan;29(1):10-21.
13. Reuter URM, Oettmeier R, Hobohm U. Safety of Therapeutic Fever Induction in Cancer Patients Using Approved PAMP Drugs. Transl Oncol. 2018 Apr;11(2):330-337.
14. Webster-Wood VA, Guix M, Xu NW, Behkam B, Sato H, Sarkar D, Sanchez S, Shimizu M, Parker KK. Biohybrid robots: recent progress, challenges, and perspectives. Bioinspir Biomim. 2022 Nov 8;18(1).
15. Choi W, Park B, Choi S, Oh D, Kim J, Kim C. Recent Advances in Contrast-Enhanced Photoacoustic Imaging: Overcoming the Physical and Practical Challenges. Chem Rev. 2023 Jun 14;123(11):7379-7419.
16. Sedighi M, Zahedi Bialvaei A, Hamblin MR, Ohadi E, Asadi A, Halajzadeh M, Lohrasbi V, Mohammadzadeh N, Amiriani T, Krutova M, Amini A, Kouhsari E. Therapeutic bacteria to combat cancer; current advances, challenges, and opportunities. Cancer Med. 2019 Jun;8(6):3167-3181.
Data Availability
The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. Authors who publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See Open Access Instruction).
- Volume Title
- Proceedings of the 3rd International Conference on Biological Engineering and Medical Science
- ISBN (Print)
- 978-1-83558-217-6
- ISBN (Online)
- 978-1-83558-218-3
- Published Date
- 20 December 2023
- Series
- Theoretical and Natural Science
- ISSN (Print)
- 2753-8818
- ISSN (Online)
- 2753-8826
- DOI
- 10.54254/2753-8818/22/20230936
- Copyright
- 20 December 2023
- Open Access
- This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited